Balancing benefits and limitations of linear energy transfer optimization in carbon ion radiotherapy for large sacral chordomas.

BACKGROUND AND PURPOSE

A low linear energy transfer (LET) in the target can reduce the effectiveness of carbon ion radiotherapy (CIRT). This study aimed at exploring benefits and limitations of LET optimization for large sacral chordomas (SC) undergoing CIRT.

MATERIALS AND METHODS

Seventeen cases were used to tune LET-based optimization, and seven to independently test interfraction plan robustness. For each patient, a reference plan was optimized on biologically-weighted dose cost functions. For the first group, 7 LET-optimized plans were obtained by increasing the gross tumor volume (GTV) minimum LET (minLET) in the range 37-55 keV/μm, in steps of 3 keV/μm. The optimal LET-optimized plan (LET) was the one maximizing LET while adhering to clinical acceptability criteria. Reference and LET plans were compared through dose and LETd metrics (D , L to x% volume) for the GTV, clinical target volume (CTV), and organs at risk (OARs). The 7 held-out cases were optimized setting minLET to the average GTV L of the investigation cohort. Both reference and LET plans were recalculated on re-evaluation CTs and compared.

RESULTS

GTV L increased from (31.8 ± 2.5)keV/μm to (47.6 ± 3.1)keV/μm on the LET plans, while the fraction of GTV receiving over 50 keV/μm increased on average by 36% (p < 0.001), without affecting target coverage goals, or impacting LET and dose to OARs. The interfraction analysis showed no significant worsening with minLET set to 48 keV/μm.

CONCLUSION

LET optimization for large SC could boost the LET in the GTV without significantly compromising plan quality, potentially improving the therapeutic effects of CIRT for large radioresistant tumors.